Compliance Risks Relating to Fair Competition Rules and On-Site Attendance in the Medical Equipment Industry
First written in FY2016. 9 of 10 entries say "Restated". Latest entry: FY2024.
2 other companies' latest entry also says "Restated".
- FY2024RestatedAnnual report
「In addition to complying with the regulations under the Act against Unjustifiable Premiums and Misleading Representations, the Group must also comply with the Fair Competition Code for the Medical Device Industry established by the Medical Device Industry Fair Trade Council, the self-regulatory organization for the industry to which our Group belongs.」
Continues to describe compliance with the Act against Unjustifiable Premiums and Misleading Representations and the Fair Competition Code for the Medical Device Industry. - FY2022RestatedAnnual report
「In addition to complying with the regulations under the Act against Unjustifiable Premiums and Misleading Representations, the Group must also comply with the Fair Competition Code for the Medical Device Industry established by the Medical Device Industry Fair Trade Council, the self-regulatory organization for the industry to which our Group belongs.」
Continues to describe compliance with the Act against Unjustifiable Premiums and Misleading Representations and the Fair Competition Code for the Medical Device Industry. - FY2020RestatedAnnual report
「In addition to complying with the regulations under the Act against Unjustifiable Premiums and Misleading Representations, the Group must also comply with the Fair Competition Code for the Medical Device Industry established by the Medical Device Industry Fair Trade Council, the self-regulatory organization for the industry to which our Group belongs.」
Continues to describe compliance with the Act against Unjustifiable Premiums and Misleading Representations and the Fair Competition Code for the Medical Device Industry. - FY2019RestatedAnnual report
「Our Group has thoroughly informed employees of the relevant standards to ensure proper attendance and has sought the understanding and cooperation of medical institutions. However, if our understanding or interpretation of the standards is inconsistent with their content, we may be found to have violated the rules, and our Group's sales and earnings could fluctuate as a result of suspension of sales, a decline in confidence, or other consequences.」
Continues to cite the risk of violations resulting from inconsistencies in the understanding and implementation of the Fair Competition Code and the attendance standards. - FY2019-Q3RestatedAnnual report
「Our Group has thoroughly informed employees of the relevant standards to ensure proper attendance and has sought the understanding and cooperation of medical institutions. However, if our understanding or interpretation of the standards is inconsistent with their content, we may be found to have violated the rules, and our Group's sales and earnings could fluctuate as a result of suspension of sales, a decline in confidence, or other consequences.」
Reiterates the risk of violations resulting from inconsistencies in the understanding and implementation of the Fair Competition Code and the attendance standards, together with measures to thoroughly inform employees and other relevant parties. - FY2019-Q2RestatedAnnual report
「Our Group has thoroughly informed employees of the relevant standards to ensure proper attendance and has sought the understanding and cooperation of medical institutions. However, if our understanding or interpretation of the standards is inconsistent with their content, we may be found to have violated the rules, and our Group's sales and earnings could fluctuate as a result of suspension of sales, a decline in confidence, or other consequences.」
Reiterates the risk of violations resulting from inconsistencies in the understanding and implementation of the Fair Competition Code and the attendance standards, together with measures to thoroughly inform employees and other relevant parties. - FY2019-Q1RestatedAnnual report
「If our understanding or interpretation of the content of the relevant standards is inconsistent with those standards, we may be found to have violated the rules, and our Group's sales and earnings could fluctuate as a result of suspension of sales, a decline in confidence, or other consequences.」
Reiterates the risk of violations in the understanding and implementation of the Fair Competition Code for the Medical Device Industry and the attendance standards. - FY2018RestatedAnnual report
「If our understanding or interpretation of the content of the relevant standards is inconsistent with those standards, we may be found to have violated the rules, and our Group's sales and earnings could fluctuate as a result of suspension of sales, a decline in confidence, or other consequences.」
Reiterates the risk of violations in the understanding and implementation of the Fair Competition Code for the Medical Device Industry and the attendance standards. - FY2017RestatedAnnual report
「If our understanding or interpretation of the content of the relevant standards is inconsistent with those standards, we may be found to have violated the rules, and our Group's sales and earnings could fluctuate as a result of suspension of sales, a decline in confidence, or other consequences.」
Reiterates the risk of violations in the understanding and implementation of the Fair Competition Code for the Medical Device Industry and the attendance standards. - FY2016First statedAnnual report
「Our Group has thoroughly informed employees of the relevant standards to ensure proper attendance and has sought the understanding and cooperation of medical institutions. However, if our understanding or interpretation of the standards is inconsistent with their content, we may be found to have violated the rules, and our Group's sales and earnings could fluctuate as a result of suspension of sales, a decline in confidence, or other consequences.」
Identifies violations of the rules, suspension of sales, and a decline in confidence resulting from inconsistencies in the understanding or interpretation of the attendance standards as risks.